PHEMI Health Systems announced today the closing of a $2.8 million seed-financing round which will allow it to commercialize PHEMI Clinical and PHEMI Central.
Investors included BDC Venture Capital, Yaletown Venture Partners and a number of strategic angel investors. PHEMI was recently included in the inaugural edition of the Techvibes 20.
PHEMI Clinical is a patient care management platform that dramatically improves clinic productivity and patient outcomes and PHEMI Central is a next generation data warehouse based on Big Data technology that incorporates sophisticated Privacy By Design principles to meet the unique demands of healthcare.
The PHEMI suite of products supports the collection, curation and analysis of many rich datasets of healthcare information for population health management, clinical study engagement, evidence-based care, post-market surveillance and quality and performance analytics.
“Over 70% of healthcare information is unstructured and difficult to mine for relevant insight using traditional methods,” said Dr. Paul Terry, CEO of PHEMI Health Systems.
“PHEMI changes that. What we’re offering now, essentially, is the ability to turn virtually any piece of patient information – physician letters, lab results, imaging, medication, previous treatment plans – into searchable information, thereby unlocking vast amounts of new data for clinicians, analysts and researchers to extract insights from. PHEMI helps turn healthcare data into strategic assets.”
Terry added in today’s press release, “We have found a way to manage patient consent and balance an individual’s privacy requirements with a healthcare organization’s legitimate need for patient information. This drives improvements in clinical care, medical innovation, business decision-making and cutting-edge research.”
Dion Madsen, Senior Managing Partner of the BDC Venture Capital Healthcare Fund, agrees, “Healthcare is an industry rapidly adopting innovative technology to drive more efficient care delivery and this rising market demand has created a great opportunity for investment. We are very impressed with the experienced PHEMI team and believe that they can build another world-class company.”